INNSZ Surgery Residency

Excited and grateful that my work has been accepted at #DDW2026! I’ll be presenting—can’t wait to learn, connect, and push our field forward together.

A couple of weeks ago, during the International Surgery Course Dr. Hector Orozco, we had the privilege of hosting @C_Roxburgh , colorectal surgeon from Glasgow 🏴󠁧󠁢󠁳󠁣󠁴󠁿. Thankful for his insights and to my mentors for fostering these invaluable learning opportunities.

New CRP Guidelines for Predicting Anastomotic Leakage in Colorectal Surgery by Zayas-Bórquez R, Canto-Losa J (...) Santes O et 2 al. in Rev Gastroenterol Mex (Engl Ed) 🪡 read our summary 👉 stitches.today/2026/01/10/new… 📖 read the article: sciencedirect.com/science/articl…

Abstract submitted to #DDW 🤞 Fingers crossed Grateful to my mentors and collaborators for their guidance and support #GITwitter #MedTwitter #ColorectalCancer app.ingo.me/q/5qc2q

Thrilled to share the publication of the APOLLO study in World Journal of Surgery. Our team at @INNSZSurgery contributed as part of this major global effort on acute colorectal cancer—and I was honored to collaborate. Full article: onlinelibrary.wiley.com/doi/10.1002/wj…

🔥 Liver Arsenal for Colorectal Cancer - who rules 2025? 🎯 Resection still reigns, but new contenders are rising fast. Here’s how every liver-directed therapy stacks up 👇 🩺 1️⃣ Resection & Ablation •Gold standard if R0 & FLR adequate •MWA > RFA 🔥 •COLLISION Trial 2025: MWA non-inferior to resection (5-yr OS 51% vs 58%) •Combo resection + ablation → ↓ hepatic failure, same DFS/OS 💉 2️⃣ Hepatic Artery Infusion (HAI) •Targets arterial tumor flow → high local FUDR dose •10-yr OS 41% vs 27% with adjuvant HAI •Conversion to resection ≈ 30–50 % •🔬 PUMP Trial ongoing (NCT05863195) ☢️ 3️⃣ Trans-Arterial Radioembolization (TARE) •Y-90 beads for chemo-refractory CRLM •↑ PFS 9.1 vs 7.2 mo, no OS gain (~14 mo) •Use selectively in expert centers 🔆 4️⃣ SBRT / MRI-LINAC •Option for inoperable oligomets < 4 cm •5-yr local control ≈ 78 %, OS ≈ 18 % 🫀 5️⃣ Transplant (TRANSMET Trial 2024) •5-yr OS 56.6 % vs 12.6 % with chemo alone •Highly selected: < 65 y, no BRAF, CEA < 80 µg/L 🧬 6️⃣ Histotripsy -Next-Gen Ultrasound Therapy •Non-invasive tumor lysis tech •HOPE4LIVER: 96 % technical success ✅ (FDA-approved 2025) •Await PFS/OS data in 2026 💡 Takeaway: No single “winner” - each liver-directed therapy plays a role. 👉 Resection offers cure, ablation extends resectability, HAI deepens control, and TARE/SBRT aid palliation or bridge to surgery. Future belongs to integration, not competition. 👉 Multidisciplinary, patient-tailored sequencing is key. 🔖 Bookmark for tumor-board pearls 📖 Folkerts AD et al. Cancer 2025 🔗 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #OncoTwitter #MedTwitter #ColorectalCancer #LiverMets @OncoAlert @myESMO @esmo_open @ASCO

🚀 Fresh out! A Random Forest model predicts distant recurrence in right-sided colon cancer with 95% accuracy (AUC 0.81). Key predictors: low lymph node count, older age, male sex, lymphovascular invasion. Toward smarter, personalized follow-up. 🔗 #ColorectalCancer #AIinMedicine

🔥Hot off the press! Systematic review (n=1,172) proposes a mortality risk scale for AML-associated neutropenic enterocolitis. Mortality 23.6%; predictors: deep neutropenia, ICU admission, comorbidities, delayed diagnosis. G-CSF use ↓ death risk (OR 0.68). #ColorectalSurgery

🎓Congratulations @sarresurgeon on graduating from #surgonc fellowship! Dr Sarre is now heading to @LHSCCanada in London, ON, as a staff surgical oncologist 👏 ✨Best wishes on this new journey! @UofTSurgery @SocSurgOnc @_CSSO

Proud to have our work presented at #ascrs2025 meeting in San Diego CA

Excited to be at the @AHPBA annual meeting! Outcomes of Liver Resection for Bile Duct Injury Treatment at a High-Volume Repair Center in Mexico @incmnszmx

"Officially finished general surgery residency with my amazing friends by my side! Couldn’t have made it through without the support, laughter, and endless teamwork. On to the next chapter! #SurgeryFam #ResidencyComplete #Grateful" @incmnszmx @INNSZSurgery

Asimismo, contamos con la presencia del Dr. Carlos Fernández del Castillo, egresado de nuestra institución y actualmente, jefe de cirugía pancreática del Massachusetts General Hospital @MGHSurgery @incmnszmx

Durante el marco del “XVIII Curso Internacional de Cirugía Dr. Héctor Orozco”, tuvimos el honor de contar con la presencia del Dr. Keith Lillemoe, jefe de cirugía del Massachusetts General Hospital @MGHSurgery @incmnszmx

Great news! our work was accepted at the ASCRS 2025 meeting #ASCRS #SanDiego #colorectal #surgery @EmmaPosadasMD

Thrilled to share our residents @SanchezPeredaD @JorgeCantoMD @jjaspersen latest work in COVID-19 related lung resections ejb.springeropen.com/articles/10.11…

Day of (multiple) MENs 🦓🦓🦓 Sharing the NETs love with this rising star @jjaspersen 😷✨

Thanks to the entire UAB Hospital Oncosurgery and Colorectal Department, for an incredible last couple of months on rotation. Your guidance and expertise have been invaluable. Grateful for the opportunity to learn from such dedicated professionals @OncologyUab 🙏 #MedEd #ThankYou

🦓What about them lymph nodes? From recent syst review: LN mets ⤴️ w PNET size & grade ▪️<2cm👉🏻median 11% ▪️>2cm👉🏻median 24% ➡️are prognostic Can't say LN dissection is therapeutic🤷🏻‍♀️ What about non-resected PNETs, differentiation of types of LN mets & their clinical meaning?